Biocryst Pharmaceuticals reported $-29582000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Adamas Pharmaceuticals ADMS:US -9155000 370K
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Biocryst Pharmaceuticals BCRX:US $ -29.58M 21.8M
Chemocentryx CCXI:US $ -38.74M 9.41M
Chugai Pharma 4519:JP Y 96712M 32745M
Daiichi Sankyo 4568:JP Y 45769M 71437M
Enanta Pharmaceuticals ENTA:US $ -33.85M 4.15M
Gilead Sciences GILD:US $ 2246M 644M
GlaxoSmithKline GSK:LN 1.68B 18M
Glaxosmithkline GSK:US $ 1675M 18M
Intra Cellular Therapies ITCI:US $ -69.14M 15.92M
IONIS PHARMACEUT IONS:US $ -81.6M 10.38M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Mirati Therapeutics MRTX:US $ -164.19M 31.76M
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Novavax NVAX:US $ -345.83M 137.2M
Ptc Therapeutics PTCT:US $ -98.49M 0.34M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
YTE INCY:US $ 140.84M 42.04M
Zogenix ZGNX:US $ -55.43M 3.63M